SELLAS Life Sciences Group, Inc. (SLS)
3.35
+0.48
(+16.72%)
USD |
NASDAQ |
Dec 29, 16:00
3.32
-0.03
(-0.90%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Liabilities (Quarterly): 5.925M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| GT Biopharma, Inc. | 1.321M |
| Geron Corp. | 318.68M |
| ADMA Biologics, Inc. | 137.50M |
| Lyell Immunopharma, Inc. | 78.84M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.56M |
| Shareholders Equity (Quarterly) | 45.63M |
| Debt to Equity Ratio | 0.0131 |
| Current Ratio | 8.279 |
| Net Debt Paydown Yield | 0.01% |